{
    "pmcid": "10069166",
    "qa_pairs": {
        "How many antibody designs were generated using the RAbD protocol in the study?": [
            "4000",
            "1000",
            "500",
            "2000"
        ],
        "What was the original target of the 80R antibody before it was redesigned to bind SARS-CoV-2?": [
            "SARS-CoV-1",
            "MERS-CoV",
            "Influenza A",
            "Ebola virus"
        ],
        "What was the range of KD values for the 10 antibody variants that showed measurable binding to the SARS-CoV-2 spike protein?": [
            "0.468 nM to 114 nM",
            "1.2 nM to 200 nM",
            "0.5 nM to 150 nM",
            "0.3 nM to 100 nM"
        ],
        "Which experimental techniques were used to measure the binding affinities of the designed antibodies?": [
            "Biolayer Interferometry (BLI) and ELISA assays",
            "Surface Plasmon Resonance (SPR) and Western Blot",
            "X-ray Crystallography and NMR Spectroscopy",
            "Flow Cytometry and Mass Spectrometry"
        ],
        "Which variant demonstrated broad binding to multiple SARS-CoV-2 variants, including Omicron and Delta?": [
            "80R_5",
            "80R_10",
            "80R_3",
            "80R_8"
        ]
    }
}